chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Spongiotic dermatitis, eczema. No previous history of eczema.
Patient immediately felt light headed (3:01pm), pt began to sweat (3:04pm), and had shakes
INCREASED BLOOD PRESSURE; DIZZINESS; CHILLS; LITTLE TIRED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included autoimmune disease, and high blood pressure.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN, expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included clonidine for high blood pressure which the patient takes four times daily. On 23-MAR-2021 11:00, the patients blood pressure was 204/105 (units not specified) and heart rate was 76 (units not specified) and started experiencing dizziness after which the patient was instructed by her doctor to recheck the blood pressure reading in 40 minutes and if got a higher reading, was advised to take an extra dose of clonidine. The patient stated that her doctor had given permission for her to get vaccinated considering her concurrent conditions. The patient was not sure if the high blood pressure was caused by covid-19 vaccine ad26.cov2.s as she had not experienced such high blood pressure before. On 23-MAR-2021, the patient experienced chills and was only a little tired. The patient had called her doctor for medical advice and was waiting to hear back from him before she took the extra dose of clonidine. Laboratory data included: Heart rate: 76 (units not specified). Laboratory data included: Blood pressure: 240/105 (units not specified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 23-MAR-2021, was recovering from little tired, had not recovered from increased blood pressure, and the outcome of dizziness was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: v0: 20210347232-covid-19 vaccine ad26.cov2.s -increased blood pressure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: UNDERLYING DISEASE
High fever, chills, shakes, redness soreness at sight of injection 6-8 hrs after, not getting better. Slightly disorientated.
This case was reported by a healthcare professional via a sales representative and described the occurrence of anaphylactic reaction in a subject of unspecified age and gender who was vaccinated with Flulaval for prophylaxis. On an unspecified date between the end of November 2007 until 18 January 2008 the subject received unspecified dose of Flulaval (.5 ml) from lot number AFLLA032AA. At an unspecified time after vaccination with Flulaval, the subject experienced anaphylactic reaction due to respiratory distress and pharmaceutical product complaint. The subject presented to the emergency room and then was hospitalised. The healthcare professional considered the events were life-threatening and disabling. At the time of reporting the outcome of the respiratory distress and anaphylactic reaction were unspecified. It was also noted that the Flulaval had not been compromised and had been stored properly. The reporter questioned if issues with this lot number had been reported by other facilities or was her facility the only one. Lot number AFLLA032AA.
BRUISING SINCE RECEIVING VACCINE; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (BRUISING SINCE RECEIVING VACCINE) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CONTUSION (BRUISING SINCE RECEIVING VACCINE). At the time of the report, CONTUSION (BRUISING SINCE RECEIVING VACCINE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient was taking blood thinners.
This case was reported by a consumer via call center representative and described the occurrence of chills in a 64-year-old male patient who received  for prophylaxis. In March 2018, the patient received the 1st dose of SHINGRIX. In March 2018, 3 hrs after receiving SHINGRIX, the patient experienced chills, lethargy and pain. On an unknown date, the outcome of the chills, lethargy and pain were recovered/resolved. It was unknown if the reporter considered the chills, lethargy and pain to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on left arm approximately 6 months before the date of reporting. Few hours after receiving SHINGRIX, the patient experienced chills, achiness, and lethargy. The symptoms continued for a day or two and then cleared. For tolerance to next dose, refer case US2018GSK180430.
lumbar facet; This is a spontaneous report received from a contactable consumer, the patient. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number unknown) via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient having epidural which was a steroid (Unspecified Medication) in his neck and patient had a lumbar facet (further clarifications were unknown). The clinical outcome of the event was unknown.  Information on Lot/Batch information has been requested.
pt recvd vax & w/in 24 hrs of vax had either an onset or an inc in apnea & required supplemental oxygen & stimulation;
This case was reported by a consumer and described the occurrence of autism in a 1 year old male subject who was vaccinated with Infanrix and Hep B vaccine (Engerix B) for prophylaxis. The reporter is the father of the subject. A physician or other health care professional has not verified this report. There were no concurrent medications. On 6/27/02, the subject received the 1st dose of Infanrix. On 8/27/02 the subject received the 2nd dose of Infanrix. On unspecified dates the subject received the 1st and 3nd dose of Engerix B. The consumer reported that at about age 1 and one half years of age on an unspecified date in 2003, the subject began showing symptoms of autism. The subject was seen by a physician and was diagnosed with autism on an unspecified date in 2004. Diagnostic test included genetic testing which showed no abnormalities and mercury levels testing, performed on an unspecified date in April 2006, that had a value of 0.1 percent, indication that the subject was not excreting mercury from his body. The subject was treated with cynocobalamin (Vitamin B12), fish oil and brain Child vitamins. At the time of the initial reporting, 11/6/06, the consumer reported that the subject, has begun speaking more and his symptoms seem to be improving. Autism was assessed as medically serious by manufacturer (OMIC).
Fever, body actes, headache, chills, nausea, diareah, sore at injection site
Anxiety; Muscles aches this all over her body that started with her upper arms and now was all over her body even in her hands and fingers; This is a spontaneous report from a contactable consumer (patient herself) via a medical information team. A 72-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EM9809), via an unspecified route of administration on 17Feb2021 as a single dose for COVID-19 immunization. The patient's medical and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3246), via an unspecified route of administration on 26Jan2021 as a single dose for COVID-19 immunization. Patient stated she was calling about the vaccination that she had in February. Patient clarified the vaccine she was referring to was the COVID-19 vaccine. Patient stated a friend of hers said if she called Pfizer, she may get some help. Patient stated she wanted to talk about this second shot that she had in February. Patient received the second dose of the Pfizer-BioNTech COVID-19 vaccine last February. Patient reported to have experienced "anxiety, muscle aches all over the body, and a queasy feeling or nausea" ever since the second shot on an unspecified date in 2021. Patient asked if these are possible side effects from the vaccine even though it has been months already. Explained to patient that there was no information found on "anxiety" as a possible side effect and that there are many factors to consider with regards to the duration of the possible side effects of the vaccine. Patient stated she had been to the emergency room several times, seen a cardiologist, general practitioner, gastrointestinal, and has had x-rays and blood tests down that have all come back negative. Patient stated she was having anxiety and muscles aches this all over her body that started with her upper arms and now was all over her body even in her hands and fingers. Patient asked if these symptoms have been reported. Patient stated also she did not mention queasy like nauseated. On an unspecified date, the patient underwent lab tests and procedures which included blood test: Negative, X-ray: Negative. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
muscle pain in left shoulder blade and under left breast; rash which resembles shingles without blistering;  redness on left should blade and over left breast
Arm was swollen for three days after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen for three days after the first dose) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen for three days after the first dose). At the time of the report, PERIPHERAL SWELLING (Arm was swollen for three days after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Description: The patient reported that her arm was swollen for three days after the first dose. Just touching it really hurt.  Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-075015 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Information regarding Prevnar (pneumococcal 7 valent conjugate vaccine (diphtheria crm197 protein) injection) was received from the mother of a 19 month old white male pt who experienced pneumonia and seizure. At 6 months of age, the pt received the third dose of Prevnar on 10Oct01. The pt also received the third dose of Diphtheria and tetanus toxoids and pertussis (manf unk) on 10Oct01. The pt has a past history of experiencing a seizure following receipt of his first and second dose of Prevnar, IPV, Comvax, and DTP (manf unk) vaccines. The child also experienced many episodes of seizures following receipt of his third doses of Prevnar and an unspecified DTP vaccine. The indication for Prevnar was immunization. Product was administered on 10Oct01. Dose regimen was 1 dose 1 time per day (IM). Concomitant medications were not reported. On an unk date in 2002, the child developed pneumonia. On 23Nov02, he experienced a seizure and died. The mother stated that the cause of death was pneumonia and a fatal seizure. No additional information was available at the time of this report.  See related serious cases: HQWYE203024OCT05, HQWYE227825OCT05, and HQWYE203124OCT05. Discharge Summary received which revealed dx: respiratory failure, sepsis syndrome & multi-system failure.
pt felt pain at injection site no other issues next morning at 9am a little swelling of bilateral upper and lower eyelids resolved on own by end of day very minimal next day not pain no itching no redness no discharge  only had ginger tea, water and put cold spoons over eyes
Subsequent to receiving first and second doses of varicella virus vaccine live on 10/5/98 and 11/5/98, the pt became pregnant. The pt tested negative for varicella virus antibodies. Additional information has been requested.
RASH ON BACK, FACE, AROUND WRISTS ON BOTH SIDES; CHILLS; MILDLY FEVERISH; This spontaneous report received from a patient concerned an 18 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy to grass, and allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 042A21A expiry: unknown) dose was not reported, administered on 12-APR-2021 10:00 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced mildly feverish. On 13-APR-2021 19:00, the subject experienced rash on back, face, around wrists on both sides. On 13-APR-2021 22:00, treatment medications included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and mildly feverish on 13-APR-2021, and had not recovered from rash on back, face, around wrists on both sides. This report was non-serious.
My two periods after each dose were heavier than normal. My third period that came a month after my second injection was 2 days late and extremely light. Late and almost not existent menstrual cycle isn?t common for me at all.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 20-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml Vls 10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided. The vaccine had an excursion of 32 degrees Fahrenheit for 304 hours. The vaccine had 2 temperatures excursions of 80 and 304 hours. The vaccine status was reported as "in excursion. The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
04/04/2022 I woke up and had foot and ankle pain when I walked. I had swelling. All continued to get worse through the month and would get very swollen at the end of the day. I have worn a wrap, brace and a boot. I had an MRI 2 weeks ago. I had gone through PT and it made it worse. I was diagnosed with Diffuse Bone Marrow Edema. The majority of it is in talon navicular. The back of the ankle also has this. I have been prescribed a prescription brace to wear. I am unable to get it until 6/22/2022.
pt recvd vax & 3 days p/vax exp fatigue, myalgia, low grade fever; the following day exp shaking chills, muscle & joint pain, & h/a; treatment: APAP;
Patient  has had nausea, vomiting, and fatigue for 5 days after getting vaccine. Patient thinks he  may have COVID. Patient vaccinated at different  facility. limited info
This spontaneous report was received from a physician assistant via a company representative and refers to 5 or 6 patients over the age of 65 years of an unknown gender. The patients' pertinent medical history, drug reactions and allergies were not provided. On unknown dates, the patients were vaccinated with PNEUMOVAX 23 (dose, lot number, route of administration, anatomical location and expiration date were not provided) for prevention of pneumococcal disease and with an unspecified influenza virus vaccine (dose, lot number, route of administration, anatomical location and expiration date were not provided). It was reported that the patients developed severe injection site reactions when co-administered with an unspecified influenza virus vaccine being administered in the opposite arm. The outcome of the event injection site reaction was unknown and causality assessment was not provided.
After the 4th dose of the Pfizer vaccination I experienced Asthma and severe Acid Reflux. I was treated by my physician with steroids azelastine was also administered. I was referred to a Gastro Specialist who performed test. I was placed on a stronger dose of ZANTAC. I was also prescribed pantoprazole for the Acid Reflux.
Patient may have inadvertently received 1cc of Moderna COVID vaccine instead of 0.5cc. Patient was notified. State of MD was notified
Started with a rash and itching, but by evening, I was in SEVERE pain 10/10...I had a lump bigger than the size of a soft ball where the shot was given, my whole arm and fingers were swollen, my neck and jaw were stiff, I couldn't move my left arm or shoulder at all, my tongue felt swollen, I started coughing in the ER waiting room, and couldn't stop and couldn't breathe out and could barely breathe in, I had to use my inhaler 4x...I had already taken 50mg of liquid Benadryl as well...I was very scared that I was about to die!
Patient given Menveo #2 vaccine at approximately 9:50 a.m., remained in clinic with provider, APNP until approximately 10:15 a.m. for remainder of visit,  with no adverse reactions to vaccine. Patient left clinic with parent and returned at 11:30 a.m. with Grandmother reporting facial puffiness and flushing starting at approximately 11:00 a.m.  Patient vitals normal, provider evaluated patient for throat or mouth swelling, injection site, any other sign of allergic reaction,  with no complaints.  Provider conferred with ER and with pediatric department and was advised to send patient to ER for evaluation.  Pt was taken to ER by Grandmother.
This spontaneous report was received from an approximately 51 year old female pharmacist reporting on herself. The pharmacist (patient) mentioned that she received an unspecified pneumococcal vaccine (manufacturer unknown and PNEUMOVAX 23 could not be ruled out), (lot # not reported) and experienced redness at the injection site for 1 week and itching. The outcome of itching and redness at the injection site was unknown. This case is linked to MARRS 1310USA004330 from the same reporter source. Additional information has been requested.
Received HPV on left deltoid, redness and swelling covering majority of upper extremity. No other symptoms/fever.
Fell out of her chair at school and had a "seizure" according to the ER physician.  Patient states she had no warning and had no symptoms or "unusual feeling".  Patient is home today with no symptoms and feeling fine.
Per patient's email - I got my vaccine on Thursday 10/31/13 in the right deltoid while at work.  Within 15-20 minutes I felt a "little funny" and a tingling sensation in my throat.  My tongue started to swell and I could feel it in the throat as well.  I did take OTC Benadryl and that helped.  After about 3.5 hours the Benadryl started to wear off and I could feel some tickling again in the throat and itching in legs and took more Benadryl.  I was ok on Friday, so stopped the Benadryl my arm was a little sore but not bad.  On Saturday my upper arm was very hot, red and swollen.  I took ibuprofen and applied ice for 20 minutes.  I went to my daughters swim meet that afternoon and when a person bumped into my right arm, it actually brought tears to my eyes because of the pain.  The swelling and redness went away finally by Monday afternoon. I have been having some allergic reactions to foods lately as well with the swelling of the throat and breathing difficulty.  It is some preservative in a very small amount that I react to.  I have had it happen with a Hershey bar, 2 different cheese spreads, cookies, and some prepackaged frozen foods.
LETHARGIC; EYE FLOATERS; ALMOST PASSED OUT; MIGRAINE TYPE OF HEADACHE; FELT NAUSEOUS; LOSS OF EFFECT; This spontaneous report received from a patient concerned a 57 year old female. The patient's concurrent conditions included sulfa allergy, non alcohol user, and non smoker, and other pre-existing medical conditions included the patient did not have any drug abuse/illicit drug. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced loss of effect. On 08-APR-2021, the subject experienced lethargic. On 08-APR-2021, the subject experienced eye floaters. On 08-APR-2021, the subject experienced almost passed out. On 08-APR-2021, the subject experienced migraine type of headache. On 08-APR-2021, the subject experienced felt nauseous. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from eye floaters, and felt nauseous on 09-APR-2021, had not recovered from migraine type of headache, and lethargic, and the outcome of almost passed out and loss of effect was not reported. This report was non-serious.
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 09-JAN-2019, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R013858, expiry date 12-JUN-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
I was awakened from a sound sleep by intense cramps in my thigh muscles (both legs) so severe I couldn't straighten my legs and had to sit up for almost 2 full minutes before I could move my legs again. It was incredibly painful at the time and I'm still sore today.
This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with the first dose of GARDASIL (dose, route, lot number not reported) and received her second doe of GARDASIL (dose, route, lot number not reported) 4 and 1/2 months after receiving her first dose of GARDASIL (date unspecified), then received her third dose of GARDASIL (dose, route, lot number not reported) less than 6 weeks after receiving her second dose of GARDASIL (date unspecified). No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. It was unknown if the patient sought medical attention. Additional information has been requested.